Medicover AB
OTC:MCVEF
Intrinsic Value
Medicover AB engages in the provision of invitro diagnostics and healthcare services. [ Read More ]
The intrinsic value of one MCVEF stock under the Base Case scenario is 22.47 USD. Compared to the current market price of 12.25 USD, Medicover AB is Undervalued by 45%.
Valuation Backtest
Medicover AB
Run backtest to discover the historical profit from buying and selling MCVEF stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Medicover AB
Current Assets | 381.3m |
Cash & Short-Term Investments | 64.4m |
Receivables | 257.5m |
Other Current Assets | 59.4m |
Non-Current Assets | 1.6B |
Long-Term Investments | 17.2m |
PP&E | 875.7m |
Intangibles | 639.2m |
Other Non-Current Assets | 27.9m |
Current Liabilities | 500.6m |
Accounts Payable | 204.6m |
Other Current Liabilities | 296m |
Non-Current Liabilities | 944.2m |
Long-Term Debt | 774.6m |
Other Non-Current Liabilities | 169.6m |
Earnings Waterfall
Medicover AB
Revenue
|
1.7B
EUR
|
Cost of Revenue
|
-1.4B
EUR
|
Gross Profit
|
359.4m
EUR
|
Operating Expenses
|
-297.5m
EUR
|
Operating Income
|
61.9m
EUR
|
Other Expenses
|
-44.3m
EUR
|
Net Income
|
17.6m
EUR
|
Free Cash Flow Analysis
Medicover AB
MCVEF Profitability Score
Profitability Due Diligence
Medicover AB's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Medicover AB's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
MCVEF Solvency Score
Solvency Due Diligence
Medicover AB's solvency score is 41/100. The higher the solvency score, the more solvent the company is.
Score
Medicover AB's solvency score is 41/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MCVEF Price Targets Summary
Medicover AB
According to Wall Street analysts, the average 1-year price target for MCVEF is 14.19 USD .
Shareholder Return
MCOV B Price
Medicover AB
Average Annual Return | 34.57% |
Standard Deviation of Annual Returns | 71.41% |
Max Drawdown | -70% |
Market Capitalization | 27.4B SEK |
Shares Outstanding | 149 652 400 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Medicover AB engages in the provision of invitro diagnostics and healthcare services. The company is headquartered in Stockholm, Stockholm and currently employs 38,555 full-time employees. The company went IPO on 2017-05-23. The company offers a broad range of healthcare services and hub-and-spoke diagnostic laboratory network, supported by proprietary software and information systems infrastructure. The firm offers its services through two divisions: Healthcare Services and Diagnostic Services. The Healthcare Services division offers services ranging from primary care to specialist outpatient and inpatient care. The care is delivered mainly through Medicover’s own network of clinics and medical facilities. The Diagnostic Services division offers a broad range of diagnostic laboratory testing for humans and some veterinary services across all main clinical pathology specialties. The firm focuses primarily on such markets, as Poland, Germany, Romania, Ukraine.
Contact
IPO
Employees
Officers
The intrinsic value of one MCVEF stock under the Base Case scenario is 22.47 USD.
Compared to the current market price of 12.25 USD, Medicover AB is Undervalued by 45%.